- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-mer
- Ligands
- 20 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 2 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.13: 14 residues within 4Å:- Chain A: D.202, N.203, Y.439, Q.440, V.445, T.465, G.466, S.467, G.468, K.469, S.470, S.471, Y.480
- Ligands: MG.14
13 PLIP interactions:13 interactions with chain A- Hydrogen bonds: A:D.202, A:G.466, A:G.466, A:S.467, A:G.468, A:K.469, A:S.470, A:S.470, A:S.471
- Salt bridges: A:K.469, A:K.469
- pi-Stacking: A:Y.439, A:Y.439
ATP.23: 18 residues within 4Å:- Chain B: E.132, Y.368, S.370, S.371, S.373, N.375, K.394, T.395, G.396, S.397, G.398, K.399, T.400, T.401, Q.441, D.521, Q.522, H.553
12 PLIP interactions:12 interactions with chain B- Hydrogen bonds: B:E.132, B:S.371, B:N.375, B:G.396, B:G.398, B:K.399, B:T.400, B:T.401, B:Q.441, B:Q.441, B:Q.441, B:Q.522
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 2 x HT1: 2'-(4-ETHOXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE(Non-covalent)
HT1.24: 16 residues within 4Å:- Chain A: H.338, R.345, D.377, N.380, R.381, Q.384
- Chain B: F.105, L.152, F.156, L.159, Y.279, G.308, M.309, I.311, W.312
- Ligands: HT1.25
13 PLIP interactions:10 interactions with chain B, 3 interactions with chain A- Hydrophobic interactions: B:F.105, B:L.152, B:F.156, B:F.156, B:L.159, B:I.311
- Hydrogen bonds: B:Y.279, A:H.338, A:Q.384
- pi-Stacking: B:W.312, B:W.312, B:W.312
- pi-Cation interactions: A:H.338
HT1.25: 21 residues within 4Å:- Chain A: E.32, Y.237, D.377, R.381, Q.384
- Chain B: I.198, G.202, I.205, H.206, F.209, D.264, F.267, E.268, V.271, K.272, V.275, G.276, Y.279, I.311, F.315
- Ligands: HT1.24
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:V.271, B:V.275, B:Y.279, B:I.311, B:F.315
- Hydrogen bonds: B:Y.279
- pi-Stacking: B:F.267
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tang, Q. et al., Asymmetric conformations and lipid interactions shape the ATP-coupled cycle of a heterodimeric ABC transporter. Nat Commun (2023)
- Release Date
- 2023-11-15
- Peptides
- Probable multidrug resistance ABC transporter ATP-binding/permease protein YheH: A
Probable multidrug resistance ABC transporter ATP-binding/permease protein YheI: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
C - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-mer
- Ligands
- 20 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 2 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 2 x HT1: 2'-(4-ETHOXYPHENYL)-5-(4-METHYL-1-PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tang, Q. et al., Asymmetric conformations and lipid interactions shape the ATP-coupled cycle of a heterodimeric ABC transporter. Nat Commun (2023)
- Release Date
- 2023-11-15
- Peptides
- Probable multidrug resistance ABC transporter ATP-binding/permease protein YheH: A
Probable multidrug resistance ABC transporter ATP-binding/permease protein YheI: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
C - Membrane
-
We predict this structure to be a membrane protein.